March was a month of RRR - Rise, Recover and Return of foreign
inflows albeit to a small extent. Earlier in the month, investor sentiment
remained cautious due to lingering concerns about the potential impact
of the tariffs by the US and their consequences globally. However,
sentiment improved after the US Federal Reserve indicated two rate
cuts this year.
Consequently, after five months of negative returns, Indian equities
ended March higher. The BSE Sensex and Nifty 50 closed 5.7% and 6.2%
higher, while the NSE Midcap 100 advanced by 7.7% and the NSE
Smallcap 100 by 9.3%. Foreign Portfolio Investors (FPIs) continued
with their cautious stance in March but the extent of outflows reduced
to US$0.4 bn. In fact, the last 5-6 sessions saw good inflows primarily on
account of attractive valuations, an appreciation in the rupee and
somewhat strong macro environment. In contrast, DIIs bought equities
worth US$ 4.3bn. With this the total outflows by FPIs in FY25 stand at
US$13.4 bn while the total inflows by DIIs add upto US$71.6 bn.
After a fall in February, US Treasury yields ended flat in March amid
concerns over the impending US slowdown as a result of the tariffs
implemented by the US. In India, the 10-year government bond yields
fell 13 basis points given liquidity infusion by the central bank, receding
inflation numbers and expectations of interest rate cuts.
Key Market Events
RBI infuses liquidity, could lower rates :
The central bank is infusing liquidity into
the system by way of open market operations (OMOs) worth Rs 80,000 cr. This will
be carried out in four tranches of Rs 20,000
crore each, on April 3, April 8, April 22 and
April 29. This would take cumulative OMO
purchases by the RBI in 2025 to INR
3,300bn. Earlier in March, it conducted
OMO purchases of government securities
worth Rs 1 lakh crore in two tranches of Rs
50,000 crore each. The central bank also
held a dollar-rupee buy/sell swap auction of
$10 billion for 36 months. All eyes are towards the monetary policy on April 9,
wherein the Reserve Bank of India is expected to lower interest rates by 25 basis
points.
Meanwhile, FY25 ended with a banking liquidity surplus of Rs 894 billion due to a
notable liquidity infusion of Rs 3.2 trillion, along with government spending and
recent FPI inflows.
Inflation falls below 4% :
Headline inflation fell to 3.6% in February from 4.3% in
January 2024, led by a faster than expected moderation in food prices especially
vegetables with the onset of winter months. Core inflation continues to remain
below 4% for over 12 months. We anticipate headline inflation to remain low due to
good rabi and kharif crop harvests and lower vegetable prices.
Rupee appreciates in March : The rupee appreciated approx. 2.4% in March vis a vis
the US dollar on account of foreign inflows in the latter part of March and a weaker
dollar itself which lost ground against most currencies. We expect the rupee to
stabilize in the near term.
US treasury yields unchanged in March : While yields fell from mid February, March
turned out to be relatively flat. Investors maintained a cautious stance towards the
reciprocal tariffs being implemented and the invariable slowdown that the US could
face.
Tariffs imposed on Indian exports could marginally slow growth : Reciprocal tariffs
were announced by the US government across countries with tariff on India being
26% which means all goods entering the US will now attract a minimum 26% levy
effective April 9, 2025. The impact on India's exports may be muted in near-term but
global growth and trade slowdown will be negative for India over the medium-term.
Equity Market View:
Tariff war and uncertainty related to it could be a key trigger for global
and Indian markets. In particular, reciprocal tariffs have been
announced across countries with tariff on India being 26% which means
all goods entering the US will now attract a minimum 26% levy effective
April 5, 2025. The impact on India's exports may be muted in near-term
but global growth and trade slowdown will be negative for India over
the medium-term. Sectors such as chemicals, electronics, gems and
jewelry, etc. face a relatively larger increase in tariffs while
pharmaceuticals have been kept out of the ambit of tariffs. India's
export to the US is dominated by textiles (furnishings and apparels),
gems and jewelry (diamonds), pharmaceutical products (medicaments),
electronics (mobile phones). Earlier, at an aggregate level, the
difference between India imposed and US imposed tariff rates ranged
between 6-10% for major exports. After the reciprocal tariffs, most
sectors (except pharma and energy) will uniformly face tariff rates at
26%. The steeper additional tariffs impact major US trading partners,
with the European Union facing a 20% and China a 34% in addition to
the existing 20%. Other key partners include South Korea at 25%, Japan
at 24% and Vietman at a steep 46%. These reciprocal tariffs are only
half the rate that other countries impose on US products and this leaves
room for negotiation.
Last month, we spoke about how the market correction (15-25% for
various indices) has brought Nifty valuations closer to their one-year
forward PE average. Following the underperformance, the India
premium has also adjusted and is now much closer to the average compared to other emerging markets. We believe that markets may
remain rangebound in the near term and the lingering effect of tariffs
may continue to dominate market sentiment.
In terms of sectors, we have been increasing exposure to financials,
particularly NBFCs and pharma, we remain overweight the consumer
discretionary segment through retailers, hotels, travel and tourism and
have reduced our overweight in automobiles and remain underweight
information technology. Renewable capex, manufacturers and power
transmission/distribution companies, defense are the other themes we
favour.
If one views India's long term growth story, the fundamentals are
supported by: 1) strong macro stability, characterized by improving
terms of trade, a declining primary deficit, and declining inflation 2)
annual earnings growth in the mid- to high-teens over the next 3-5
years, driven by an emerging private capital expenditure cycle, the releveraging
of corporate balance sheets, and a structural increase in
discretionary consumption.
Debt Market View:
We expect an overall shallow interest rate cut cycle of 25-50 bps in next
6-12 months with 25 bps coming up in the April monetary policy
meeting and a long pause thereafter. As mentioned earlier, the central
bank proactively managed liquidity infusion to anchor the overnight
rates to the policy rates. Despite rate cut and slew of liquidity
measures, short end CDs and 3-5 year corporate bond yields have
hardened and spreads have widened due to higher supply. OMO
purchases and measured supply in Govt bonds have led G-Sec yields to
rally by 5-10 bps. We believe that the liquidity infusion has been more
than sufficient to ensure Core liquidity remains in surplus in near term.
Core/durable liquidity has shifted from a deficit of INR 1 trillion in Dec
to a surplus of INR 1.5 trillion by March 25 and is expected to be above
INR 2.5 trillion by Sept 2025. Announcement of RBI dividend by June
2025 of INR 2.5 trillion would be another big boost to core / durable
liquidity and hence we believe core/ durable liquidity to remain in
surplus from April 2025 for H1 FY 2025-26. Positive liquidity augurs
well for short end of the curve and we expect the curve to get steeper
over the next 6 months as compared to flat/invert yield curve.
In the US, we believe rate cuts could be to the tune of 50-75 basis points.
Growth is indeed slowing down as seen by the weaker data such as GDP
growth, lower inflation and other macros. The tariff measures
implemented by the US on its top trading partners will hurt growth over
the medium term.
Source: Bloomberg, Axis MF Research.